Next Article in Journal
Desmoid Tumors in Pregnant and Postpartum Women
Previous Article in Journal
Does Secondary Inflammatory Breast Cancer Represent Post-Surgical Metastatic Disease?
Cancers 2012, 4(1), 165-183; doi:10.3390/cancers4010165
Review

Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in Japan

* ,
,
 and
Received: 16 January 2012 / Revised: 8 February 2012 / Accepted: 16 February 2012 / Published: 21 February 2012
View Full-Text   |   Download PDF [223 KB, uploaded 21 February 2012]

Abstract

Transcatheter methods such as transcatheter arterial chemoembolization (TACE) and hepatic arterial infusion chemotherapy (HAIC) have an important role in the treatment for advanced hepatocellular carcinoma (HCC). Recently, sorafenib, an inhibitor of tyrosine kinases, has been found to obtain survival benefits in patients with HCC, leading to major advances in the treatment of advanced HCC. However, it is associated with a low tumor response rate, minimal survival advantage, and high rates of adverse events. On the other hand, high rates of objective treatment response with HAIC for advanced HCC have been reported, although convincing evidence of it contributing to overall survival in HAIC has been lacking. In Japan, HAIC still tends to be the preferred method for the treatment of advanced HCC, even in patients with poor liver function. However, the choice of chemotherapeutic agents in TACE/HAIC for HCC varies between institutions. In this review, based on studies reported to date in the literature, we refer to current knowledge regarding the chemotherapeutic agents used for TACE/HAIC for HCC in Japan and consider the future perspectives for HAIC for this cancer.
Keywords: advanced hepatocellular carcinoma; chemotherapy; hepatic arterial infusion chemotherapy; sorafenib; response rate advanced hepatocellular carcinoma; chemotherapy; hepatic arterial infusion chemotherapy; sorafenib; response rate
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Nishikawa, H.; Osaki, Y.; Kita, R.; Kimura, T. Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in Japan. Cancers 2012, 4, 165-183.

View more citation formats

Related Articles

Article Metrics

Comments

Citing Articles

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert